Stock & Company Details
Acrivon Therapeutics Inc $ACRV
Price:
N/A
N/A
43M
$80M
52 Week High:
N/A
10 Day Average Volume:
N/A
-0.93
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
ACRV technical indicators
Latest Acrivon Therapeutics Inc (ACRV) indicator readings as of 2026-10-08.
ACRV's 14-day RSI is 43.0, in neutral territory. ADX reads 19.3, indicating a range-bound market rather than a trend. MACD (12, 26, 9) is -0.02, below the zero line.
Overview
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Company matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.
Finance Bot
Ask your questions
Start by typing a question below.
